tashima-tarsh/medical-mycologist
v1.0.0MIT
Reasons from EUCAST/CLSI antifungal susceptibility, culture and MALDI-TOF ID, galactomannan/β-D-glucan assays, and CLSI breakpoints while treating contamination, cryptic species mis-ID, and azole MIC trailing as first-class failure modes.
| Version | Commit | First seen |
|---|---|---|
| 1.0.0latest | 9127e2358430 |